223 related articles for article (PubMed ID: 36555852)
21. The influence of bexarotene, a selective agonist of the retinoid receptor X (RXR), and tazarotene, a selective agonist of the retinoid acid receptor (RAR), on bone metabolism in rats.
Nowak B; Matuszewska A; Filipiak J; Nikodem A; Merwid-Ląd A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A
Adv Med Sci; 2016 Mar; 61(1):85-9. PubMed ID: 26569440
[TBL] [Abstract][Full Text] [Related]
22. A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics.
Hanish BJ; Hackney Price JF; Kaneko I; Ma N; van der Vaart A; Wagner CE; Jurutka PW; Marshall PA
Steroids; 2018 Jul; 135():36-49. PubMed ID: 29704526
[TBL] [Abstract][Full Text] [Related]
23. Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
Inoue M; Tanabe H; Nakashima K; Ishida Y; Kotani H
J Nat Prod; 2014 Jul; 77(7):1670-7. PubMed ID: 24959987
[TBL] [Abstract][Full Text] [Related]
24. Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptor.
Lin JH; Kim EJ; Bansal A; Seykora J; Richardson SK; Cha XY; Zafar S; Nasta S; Wysocka M; Benoit B; Rook AH; Fakharzadeh SS
Blood; 2008 Sep; 112(6):2484-8. PubMed ID: 18559673
[TBL] [Abstract][Full Text] [Related]
25. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action.
Zhang C; Hazarika P; Ni X; Weidner DA; Duvic M
Clin Cancer Res; 2002 May; 8(5):1234-40. PubMed ID: 12006543
[TBL] [Abstract][Full Text] [Related]
26. Retinoid X receptor-mediated neuroprotection via CYP19 upregulation and subsequent increases in estradiol synthesis.
Ishihara Y; Sakurai H; Oguro A; Tsuji M; Vogel CFA; Yamazaki T
J Steroid Biochem Mol Biol; 2019 Oct; 193():105421. PubMed ID: 31265900
[TBL] [Abstract][Full Text] [Related]
27. Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity.
Mounier A; Georgiev D; Nam KN; Fitz NF; Castranio EL; Wolfe CM; Cronican AA; Schug J; Lefterov I; Koldamova R
J Neurosci; 2015 Aug; 35(34):11862-76. PubMed ID: 26311769
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.
Beard RL; Chandraratna RA; Colon DF; Gillett SJ; Henry E; Marler DK; Song T; Denys L; Garst ME; Arefieg T
J Med Chem; 1995 Jul; 38(15):2820-9. PubMed ID: 7636843
[TBL] [Abstract][Full Text] [Related]
29. Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer.
Leal AS; Hung PY; Chowdhury AS; Liby KT
Pharmacol Ther; 2023 Dec; 252():108561. PubMed ID: 37952906
[TBL] [Abstract][Full Text] [Related]
30. Modulation of RXR function through ligand design.
Pérez E; Bourguet W; Gronemeyer H; de Lera AR
Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
[TBL] [Abstract][Full Text] [Related]
31. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
[TBL] [Abstract][Full Text] [Related]
32. Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.
Dummer R; Beyer M; Hymes K; Epping MT; Bernards R; Steinhoff M; Sterry W; Kerl H; Heath K; Ahern JD; Hardwick JS; Garcia-Vargas J; Baumann K; Rizvi S; Frankel SR; Whittaker SJ; Assaf C
Leuk Lymphoma; 2012 Aug; 53(8):1501-8. PubMed ID: 22239668
[TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.
Boehm MF; Zhang L; Zhi L; McClurg MR; Berger E; Wagoner M; Mais DE; Suto CM; Davies JA; Heyman RA
J Med Chem; 1995 Aug; 38(16):3146-55. PubMed ID: 7636877
[TBL] [Abstract][Full Text] [Related]
34. RARα/RXR synergism potentiates retinoid responsiveness in cutaneous T-cell lymphoma cell lines.
Wang L; DeMarco SS; Peaks MS; Maiorana-Boutilier AL; Chen J; Crouch MJ; Shewchuk BM; Shaikh SR; Phillips CM; Bridges LC
Exp Dermatol; 2017 Nov; 26(11):1004-1011. PubMed ID: 28370539
[TBL] [Abstract][Full Text] [Related]
35. The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer.
Moerland JA; Zhang D; Reich LA; Carapellucci S; Lockwood B; Leal AS; Krieger-Burke T; Aleiwi B; Ellsworth E; Liby KT
Sci Rep; 2020 Dec; 10(1):22244. PubMed ID: 33335263
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway.
Zhao J; Fu Y; Liu CC; Shinohara M; Nielsen HM; Dong Q; Kanekiyo T; Bu G
J Biol Chem; 2014 Apr; 289(16):11282-11292. PubMed ID: 24599963
[TBL] [Abstract][Full Text] [Related]
37. Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression.
Klopper JP; Sharma V; Berenz A; Hays WR; Loi M; Pugazhenthi U; Said S; Haugen BR
Mol Cancer; 2009 Mar; 8():16. PubMed ID: 19267912
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional modulations by RXR agonists are only partially subordinated to PPARalpha signaling and attest additional, organ-specific, molecular cross-talks.
Martin PG; Lasserre F; Calleja C; Van Es A; Roulet A; Concordet D; Cantiello M; Barnouin R; Gauthier B; Pineau T
Gene Expr; 2005; 12(3):177-92. PubMed ID: 16128002
[TBL] [Abstract][Full Text] [Related]
39. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
[TBL] [Abstract][Full Text] [Related]
40. Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents.
Standeven AM; Thacher SM; Yuan YD; Escobar M; Vuligonda V; Beard RL; Chandraratna RA
Biochem Pharmacol; 2001 Dec; 62(11):1501-9. PubMed ID: 11728386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
